See more : Tips Industries Limited (TIPSINDLTD.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Protalix BioTherapeutics, Inc. (PLX.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Protalix BioTherapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- HKBN Ltd. (HKBNF) Income Statement Analysis – Financial Results
- Unipres Corporation (5949.T) Income Statement Analysis – Financial Results
- Lionsgate Studios Corp. (LION) Income Statement Analysis – Financial Results
- Danske Invest – Danmark Indeks ex OMXC20 (DKIDKIEXOMXC20D.CO) Income Statement Analysis – Financial Results
- AirBoss of America Corp. (BOS.TO) Income Statement Analysis – Financial Results
Protalix BioTherapeutics, Inc. (PLX.TA)
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47.64M | 38.35M | 62.90M | 54.69M | 34.24M | 19.24M | 9.20M | 4.36M | 15.16M | 11.51M | 34.42M | 8.39M | 6.64M | 388.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 3.55M | 8.04M | 0.00 | 0.00 |
| Cost of Revenue | 19.59M | 16.35M | 10.87M | 10.90M | 9.30M | 15.23M | 8.40M | 730.00K | 9.05M | 5.43M | 8.14M | 6.94M | 8.99M | 3.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.68M | 6.31M | 0.00 | 0.00 |
| Gross Profit | 28.05M | 22.00M | 52.03M | 43.80M | 24.94M | 4.01M | 801.00K | 3.63M | 6.11M | 6.09M | 26.28M | 1.44M | -2.34M | -3.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 871.16K | 1.73M | 0.00 | 0.00 |
| Gross Profit Ratio | 58.87% | 57.37% | 82.71% | 80.08% | 72.83% | 20.85% | 8.71% | 83.27% | 40.28% | 52.85% | 76.34% | 17.21% | -35.28% | -821.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 24.51% | 21.53% | 0.00% | 0.00% |
| Research & Development | 29.35M | 29.73M | 38.17M | 44.62M | 33.33M | 28.83M | 24.61M | 20.03M | 21.65M | 24.82M | 28.69M | 31.04M | 29.95M | 21.64M | 17.40M | 12.86M | 5.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.39M | 9.76M | 0.00 | 6.88M | 7.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.71M | 12.73M | 11.15M | 9.90M | 10.92M | 11.53M | 9.36M | 7.28M | 9.66M | 8.39M | 9.76M | 6.93M | 6.88M | 7.14M | 6.77M | 11.71M | 4.53M | 93.30K | 165.58K | 147.39K | 165.79K | 291.79K | 381.85K | 1.52M | 2.09M | 164.38K | 44.06K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 94.00K | 0.00 | 163.20K | 817.93K | 0.00 | 0.00 |
| Operating Expenses | 41.06M | 42.46M | 49.32M | 54.52M | 44.25M | 40.36M | 33.96M | 27.30M | 31.31M | 33.20M | 38.45M | 37.97M | 36.83M | 28.78M | 24.17M | 24.57M | 9.77M | 93.30K | 165.58K | 147.39K | 165.79K | 385.79K | 381.85K | 1.69M | 2.90M | 164.38K | 44.06K |
| Cost & Expenses | 60.65M | 58.81M | 60.19M | 65.41M | 53.55M | 55.60M | 42.36M | 28.03M | 40.36M | 38.63M | 46.60M | 44.92M | 45.81M | 32.36M | 24.17M | 24.57M | 9.77M | 93.30K | 165.58K | 147.39K | 165.79K | 385.79K | 381.85K | 4.37M | 9.21M | 164.38K | 44.06K |
| Interest Income | 1.15M | 401.00K | 438.00K | 407.00K | 536.00K | 188.00K | 589.00K | 123.00K | 196.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.76M | 2.08M | 344.00K | 14.15K | 5.51K | 6.67K | 15.72K | 56.62K | 126.01K | 0.00 | 78.84K | 0.00 | 243.74K |
| Interest Expense | 2.53M | 7.52M | 9.67M | 7.97M | 7.69M | 9.73M | 10.67M | 3.74M | 4.94M | -674.00K | 554.00K | 2.00K | 968.00K | 529.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 51.57K | 0.00 | 0.00 |
| Depreciation & Amortization | 2.23M | 401.00K | 1.30M | 2.02M | 1.67M | 1.92M | 1.98M | 2.37M | 3.14M | 3.54M | 3.69M | 3.63M | 3.13M | 1.99M | 1.30M | 759.00K | 502.00K | 18.36K | 5.51K | 6.67K | 16.03K | 56.62K | 276.24K | 163.20K | 202.21K | 343.84K | 243.74K |
| EBITDA | -10.78M | -20.06M | 3.15M | -8.69M | -17.10M | -73.63M | -16.72M | 64.14M | -21.87M | -24.93M | -7.37M | -32.90M | -24.90M | -28.92M | -21.11M | -21.72M | -8.89M | -74.93K | -160.07K | -140.71K | -149.76K | -329.17K | -105.61K | -834.67K | -893.03K | 179.46K | 199.69K |
| EBITDA Ratio | -22.63% | -52.31% | 5.00% | -15.89% | -49.94% | -382.66% | -181.73% | 1,469.80% | -144.25% | -216.49% | -21.42% | -392.27% | -374.84% | -7,453.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -10,560,900.00% | -23.48% | -11.11% | 0.00% | 0.00% |
| Operating Income | -13.01M | -20.46M | 1.85M | -10.72M | -19.31M | -36.35M | -33.16M | -23.67M | -25.20M | -27.12M | -12.17M | -36.53M | -29.97M | -31.97M | -24.17M | -24.57M | -9.77M | -93.30K | -165.58K | -147.39K | -165.79K | -385.79K | -381.85K | -816.21K | -1.17M | -164.38K | -44.06K |
| Operating Income Ratio | -27.32% | -53.36% | 2.93% | -19.59% | -56.39% | -188.93% | -360.51% | -542.39% | -166.25% | -235.53% | -35.36% | -435.62% | -451.16% | -8,239.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -38,185,100.00% | -22.96% | -14.61% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.38M | -7.12M | -9.23M | -7.56M | -7.15M | -48.92M | 3.99M | -3.61M | -4.74M | -674.00K | 554.00K | 0.00 | 0.00 | 0.00 | 0.00 | 6.00K | 0.00 | 4.21K | 0.00 | 0.00 | 312.00 | -94.00K | 150.23K | -254.48K | 0.00 | 343.84K | 243.74K |
| Income Before Tax | -14.40M | -27.58M | -6.52M | -18.28M | -26.46M | -85.28M | -29.18M | -27.28M | -29.94M | -27.79M | -11.62M | 0.00 | 0.00 | 0.00 | 0.00 | -24.56M | 0.00 | -89.08K | 0.00 | 0.00 | -165.48K | -479.79K | -231.62K | -1.07M | 0.00 | 179.46K | 199.69K |
| Income Before Tax Ratio | -30.22% | -71.92% | -10.37% | -33.42% | -77.27% | -443.18% | -317.16% | -625.16% | -197.51% | -241.38% | -33.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -23,162,100.00% | -30.12% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 530.00K | 6.40M | 8.37M | 7.97M | 536.00K | -39.20M | 14.65M | 123.00K | 196.00K | -1.35M | 1.11M | 2.00K | 968.00K | 529.00K | 0.00 | 6.00K | 0.00 | -14.15K | -5.51K | -6.67K | -15.72K | -150.62K | -126.01K | -254.48K | 51.57K | 61.02K | 68.00K |
| Net Income | -14.93M | -33.99M | -14.89M | -26.24M | -26.46M | -85.28M | -29.37M | 58.04M | -29.94M | -27.79M | -11.62M | -36.53M | -29.00M | -31.44M | -22.41M | -22.48M | -9.39M | -74.93K | -160.07K | -140.71K | -149.76K | -329.17K | -105.61K | -997.87K | -1.15M | 118.45K | 131.68K |
| Net Income Ratio | -31.33% | -88.62% | -23.68% | -47.98% | -77.27% | -443.18% | -319.22% | 1,329.90% | -197.51% | -241.38% | -33.75% | -435.60% | -436.59% | -8,103.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -10,560,900.00% | -28.07% | -14.27% | 0.00% | 0.00% |
| EPS | -0.31 | -0.77 | -0.51 | -1.77 | -17.98 | -6.51 | -28.96 | 61.14 | -32.23 | -30.09 | -12.79 | -43.16 | -35.82 | -40.86 | -29.53 | -33.46 | -32.05 | -23.69 | -54.91 | -48.27 | -51.38 | -101.97 | -26.31 | -191.27 | -251.27 | 46.63 | 60.82 |
| EPS Diluted | -0.31 | -0.77 | -0.51 | -1.77 | -17.98 | -6.51 | -28.96 | 61.14 | -32.23 | -30.09 | -12.79 | -43.16 | -35.82 | -40.86 | -29.53 | -33.46 | -32.05 | -23.69 | -54.91 | -48.27 | -51.38 | -101.97 | -26.31 | -191.27 | -251.27 | 46.58 | 60.82 |
| Weighted Avg Shares Out | 48.47M | 44.14M | 29.15M | 14.84M | 1.47M | 13.11M | 1.01M | 949.22K | 928.92K | 923.68K | 908.46K | 846.45K | 809.60K | 769.43K | 758.91K | 671.87K | 293.01K | 3.16K | 2.92K | 2.92K | 2.92K | 3.23K | 4.01K | 5.22K | 4.56K | 2.54K | 2.17K |
| Weighted Avg Shares Out (Dil) | 48.47M | 44.14M | 29.15M | 14.84M | 1.47M | 13.11M | 1.01M | 949.22K | 928.92K | 923.68K | 908.46K | 846.45K | 809.60K | 769.43K | 758.91K | 671.87K | 293.01K | 3.16K | 2.92K | 2.92K | 2.92K | 3.23K | 4.01K | 5.22K | 4.56K | 2.54K | 2.17K |
Source: https://incomestatements.info
Category: Stock Reports